The Rise of Coccidioides: Forces Against the Dust Devil Unleashed

Marley C.Caballero Van Dyke, George R. Thompson, John N. Galgiani, Bridget M. Barker

Research output: Contribution to journalReview article

Abstract

Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of Coccidioides posadasii or C. immitis. This neglected disease occurs in the desert areas of the western United States, most notably in California and Arizona, where infections continue to rise. Clinically, coccidioidomycosis ranges from asymptomatic to severe pulmonary disease and can disseminate to the brain, skin, bones, and elsewhere. New estimates suggest as many as 350,000 new cases of coccidioidomycosis occur in the United States each year. Thus, there is an urgent need for the development of a vaccine and new therapeutic drugs against Coccidioides infection. In this review, we discuss the battle against Coccidioides including the development of potential vaccines, the quest for new therapeutic drugs, and our current understanding of the protective host immune response to Coccidioides infection.

Original languageEnglish (US)
Article number2188
JournalFrontiers in immunology
Volume10
DOIs
StatePublished - Sep 11 2019

Fingerprint

Coccidioides
Coccidioidomycosis
Dust
Vaccines
Infection
Neglected Diseases
Mycoses
Pharmaceutical Preparations
Inhalation
Lung Diseases
Bone and Bones
Skin
Brain
Therapeutics

Keywords

  • antifungal drugs
  • Coccidioides
  • fungal vaccines
  • immunity
  • valley fever

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The Rise of Coccidioides : Forces Against the Dust Devil Unleashed. / Van Dyke, Marley C.Caballero; Thompson, George R.; Galgiani, John N.; Barker, Bridget M.

In: Frontiers in immunology, Vol. 10, 2188, 11.09.2019.

Research output: Contribution to journalReview article

Van Dyke, Marley C.Caballero ; Thompson, George R. ; Galgiani, John N. ; Barker, Bridget M. / The Rise of Coccidioides : Forces Against the Dust Devil Unleashed. In: Frontiers in immunology. 2019 ; Vol. 10.
@article{fc7bbfb06e9e4336b522444996454d33,
title = "The Rise of Coccidioides: Forces Against the Dust Devil Unleashed",
abstract = "Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of Coccidioides posadasii or C. immitis. This neglected disease occurs in the desert areas of the western United States, most notably in California and Arizona, where infections continue to rise. Clinically, coccidioidomycosis ranges from asymptomatic to severe pulmonary disease and can disseminate to the brain, skin, bones, and elsewhere. New estimates suggest as many as 350,000 new cases of coccidioidomycosis occur in the United States each year. Thus, there is an urgent need for the development of a vaccine and new therapeutic drugs against Coccidioides infection. In this review, we discuss the battle against Coccidioides including the development of potential vaccines, the quest for new therapeutic drugs, and our current understanding of the protective host immune response to Coccidioides infection.",
keywords = "antifungal drugs, Coccidioides, fungal vaccines, immunity, valley fever",
author = "{Van Dyke}, {Marley C.Caballero} and Thompson, {George R.} and Galgiani, {John N.} and Barker, {Bridget M.}",
year = "2019",
month = "9",
day = "11",
doi = "10.3389/fimmu.2019.02188",
language = "English (US)",
volume = "10",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - The Rise of Coccidioides

T2 - Forces Against the Dust Devil Unleashed

AU - Van Dyke, Marley C.Caballero

AU - Thompson, George R.

AU - Galgiani, John N.

AU - Barker, Bridget M.

PY - 2019/9/11

Y1 - 2019/9/11

N2 - Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of Coccidioides posadasii or C. immitis. This neglected disease occurs in the desert areas of the western United States, most notably in California and Arizona, where infections continue to rise. Clinically, coccidioidomycosis ranges from asymptomatic to severe pulmonary disease and can disseminate to the brain, skin, bones, and elsewhere. New estimates suggest as many as 350,000 new cases of coccidioidomycosis occur in the United States each year. Thus, there is an urgent need for the development of a vaccine and new therapeutic drugs against Coccidioides infection. In this review, we discuss the battle against Coccidioides including the development of potential vaccines, the quest for new therapeutic drugs, and our current understanding of the protective host immune response to Coccidioides infection.

AB - Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of Coccidioides posadasii or C. immitis. This neglected disease occurs in the desert areas of the western United States, most notably in California and Arizona, where infections continue to rise. Clinically, coccidioidomycosis ranges from asymptomatic to severe pulmonary disease and can disseminate to the brain, skin, bones, and elsewhere. New estimates suggest as many as 350,000 new cases of coccidioidomycosis occur in the United States each year. Thus, there is an urgent need for the development of a vaccine and new therapeutic drugs against Coccidioides infection. In this review, we discuss the battle against Coccidioides including the development of potential vaccines, the quest for new therapeutic drugs, and our current understanding of the protective host immune response to Coccidioides infection.

KW - antifungal drugs

KW - Coccidioides

KW - fungal vaccines

KW - immunity

KW - valley fever

UR - http://www.scopus.com/inward/record.url?scp=85072786643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072786643&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2019.02188

DO - 10.3389/fimmu.2019.02188

M3 - Review article

C2 - 31572393

AN - SCOPUS:85072786643

VL - 10

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

M1 - 2188

ER -